Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Beontag – CCRR Group (”Beontag”) in connection with the acquisition of Scandstick AB with subsidiaries and Linerless AB (the “Scandstick Group”)
Mandate

Vinge advises Beontag – CCRR Group (”Beontag”) in connection with the acquisition of Scandstick AB with subsidiaries and Linerless AB (the “Scandstick Group”)

February 10, 2022 M&A Employment and Benefits

Vinge advises Beontag in connection with the acquisition of the Scandstick Group. Scandstick is an international group in the self adhesive industry with head office in Höganäs, Sweden. The Scandstick Group has approximately 150 employees and production facilities in Sweden, Slovenia, Poland and Belgium.

Beontag is the largest manufacturer in Latin America of RAIN RFID inlays and tags.

Vinge’s team consisted of Magnus Pauli, Sofie Nordgren (Project Manager), Johanna Hamrefält (M&A manager), Tilda Hall (Commercial and Real Estate) Agaton Lindgren (Finance) and Anna Ståhlklo (Employment), among others.

Selih & Partnerji in Slovenia, Wardynski & Partners in Poland and Liedekerke in Belgium acted as local counsels in connection with the transaction.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025